1-108834468-C-G
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_152763.5(AKNAD1):c.1725G>C(p.Met575Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000683 in 1,610,952 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_152763.5 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
AKNAD1 | NM_152763.5 | c.1725G>C | p.Met575Ile | missense_variant | Exon 9 of 16 | ENST00000370001.8 | NP_689976.2 | |
AKNAD1 | NR_049760.2 | n.1958+3082G>C | intron_variant | Intron 8 of 13 | ||||
LOC105378891 | XR_007066273.1 | n.294+132C>G | intron_variant | Intron 3 of 4 | ||||
LOC105378891 | XR_947687.3 | n.269+132C>G | intron_variant | Intron 3 of 4 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000658 AC: 1AN: 151948Hom.: 0 Cov.: 31 show subpopulations
GnomAD2 exomes AF: 0.00000811 AC: 2AN: 246720 AF XY: 0.0000150 show subpopulations
GnomAD4 exome AF: 0.00000685 AC: 10AN: 1459004Hom.: 0 Cov.: 31 AF XY: 0.00000965 AC XY: 7AN XY: 725422 show subpopulations
GnomAD4 genome AF: 0.00000658 AC: 1AN: 151948Hom.: 0 Cov.: 31 AF XY: 0.0000135 AC XY: 1AN XY: 74212 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.1725G>C (p.M575I) alteration is located in exon 9 (coding exon 8) of the AKNAD1 gene. This alteration results from a G to C substitution at nucleotide position 1725, causing the methionine (M) at amino acid position 575 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at